![Airtalk artwork](https://is4-ssl.mzstatic.com/image/thumb/Podcasts123/v4/04/5a/d2/045ad247-2779-11a7-7a69-3aa2d21e80c7/mza_8545947000242619737.jpg/100x100bb.jpg)
COVID-19 AMA More J&J Vaccines Likely On The Way, Drug Makers Turn Focus To Variants And More
Airtalk
English - March 10, 2021 20:21 - 17 minutes - 16.5 MB - ★★★★★ - 96 ratingsNews Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
In our continuing series looking at the latest medical research and news on COVID-19, we speak with Dr. Richard Riggs from Cedars-Sinai Medical Center.
Today’s topics include:
How has the PPE supply chain evolved?
As case numbers go down, how is medical worker burn out?
Biden announces deal for additional Johnson & Johnson vaccines
Vaccines in the works to target multiple variants
Study: UK variant has higher death rate
Pfizer-BioNTech vaccine could neutralize Brazil variant
How far is Calif. from a post-pandemic “normal?”
Guest:
Richard Riggs, M.D., senior vice president of medical affairs and chief medical officer at Cedars-Sinai Medical Center
In our continuing series looking at the latest medical research and news on COVID-19, we speak with Dr. Richard Riggs from Cedars-Sinai Medical Center.
Today’s topics include:
How has the PPE supply chain evolved?
As case numbers go down, how is medical worker burn out?
Biden announces deal for additional Johnson & Johnson vaccines
Vaccines in the works to target multiple variants
Study: UK variant has higher death rate
Pfizer-BioNTech vaccine could neutralize Brazil variant
How far is Calif. from a post-pandemic “normal?”
Guest:
Richard Riggs, M.D., senior vice president of medical affairs and chief medical officer at Cedars-Sinai Medical Center